retatrutide youtube TikTok influencers fuelling parallel market for unlicensed weight-loss drug | Consumer affairs Retatrutide Myths Debunked: What Reddit

Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)

Always follow a medical plan tailored to your needs and goals

It works by improving insulin sensitivity, activating AMPK (an enzyme that boosts fat burning), and enhancing mitochondrial function to increase overall energy production

Es ist wichtig, die Anwendung auf einen Zyklus von 4-6 Wochen zu beschrnken, um bernutzung zu vermeiden und die Wirksamkeit aufrechtzuerhalten